New imaging technique could spot liver scarring earlier in PSC patients
NCT ID NCT06252610
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study will test whether a special PET/MRI scan can better detect and measure scarring (fibrosis) in the bile ducts of people with primary sclerosing cholangitis (PSC). Ten adults with PSC will receive two different radioactive tracers during the scan, and results will be compared to standard tests like FibroScan. The goal is to improve non-invasive diagnosis of liver fibrosis in PSC.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School
Charlestown, Massachusetts, 02129, United States
Conditions
Explore the condition pages connected to this study.